Intelligent Bio Solutions Inc.
INBS
$2.40
$0.051.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.06M | 896.80K | 1.11M | 843.90K | 728.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.06M | 896.80K | 1.11M | 843.90K | 728.90K |
| Cost of Revenue | 525.40K | 437.00K | 593.50K | 508.30K | 387.50K |
| Gross Profit | 535.40K | 459.70K | 518.30K | 335.60K | 341.40K |
| SG&A Expenses | 2.46M | 2.34M | 2.66M | 2.72M | 2.41M |
| Depreciation & Amortization | 290.40K | 281.90K | 303.40K | 300.30K | 302.00K |
| Other Operating Expenses | -165.70K | -72.70K | -193.30K | -383.90K | -173.30K |
| Total Operating Expenses | 4.00M | 3.51M | 3.85M | 3.73M | 3.29M |
| Operating Income | -2.94M | -2.61M | -2.74M | -2.88M | -2.56M |
| Income Before Tax | -2.87M | -2.69M | -3.00M | -3.10M | -2.55M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.87M | -2.69M | -3.00M | -3.10M | -2.55M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.90K | 9.00K | 12.00K | 12.50K | 7.10K |
| Net Income | -2.86M | -2.68M | -2.98M | -3.09M | -2.54M |
| EBIT | -2.94M | -2.61M | -2.74M | -2.88M | -2.56M |
| EBITDA | -2.81M | -2.28M | -2.48M | -2.64M | -2.44M |
| EPS Basic | -1.80 | -2.82 | -3.49 | -4.42 | -4.41 |
| Normalized Basic EPS | -1.12 | -1.74 | -1.98 | -2.56 | -2.75 |
| EPS Diluted | -1.80 | -2.82 | -3.49 | -4.42 | -4.41 |
| Normalized Diluted EPS | -1.12 | -1.74 | -1.98 | -2.56 | -2.75 |
| Average Basic Shares Outstanding | 1.59M | 950.80K | 854.70K | 699.90K | 577.20K |
| Average Diluted Shares Outstanding | 1.59M | 950.80K | 854.70K | 699.90K | 577.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |